Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-22T18:55:07.405Z Has data issue: false hasContentIssue false

MAPT mutation associated with frontotemporal dementia and parkinsonism (FTDP-17)

Published online by Cambridge University Press:  01 December 2016

Robert Haussmann*
Affiliation:
Department of Psychiatry, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
Marek Wysocki
Affiliation:
Department of Psychiatry, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
Moritz D. Brandt
Affiliation:
Department of Neurology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
Andreas Hermann
Affiliation:
Department of Neurology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany German Center for Neurodegenerative Diseases (DZNE), Research Site Dresden, Dresden, Germany
Markus Donix
Affiliation:
Department of Psychiatry, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany German Center for Neurodegenerative Diseases (DZNE), Research Site Dresden, Dresden, Germany
*
Correspondence should be addressed to: Robert Haussmann, MD, Fetscherstraße 74, 01307 Dresden, Germany. Phone: +49351-458-3561; Fax: +49351-458-5380. Email: robert.haussmann@uniklinikum-dresden.
Get access

Abstract

We present a 56-year-old patient suffering from frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17). The history included a three-generation pedigree and the patient was found to be a mutation carrier. The diagnosis was hindered by late appearance of the hypokinetic movement disorder. For clinicians, it is important to consider rare neurodegenerative disease variants in early-onset familial dementia syndromes with behavioral, cognitive, and motor symptoms.

Type
Case Report
Copyright
Copyright © International Psychogeriatric Association 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Desikan, R. et al. (2015). Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus. Molecular Psychiatry 20, 15881595. doi: 10.1038/mp.2015.6.CrossRefGoogle ScholarPubMed
Hutton, M. et al. (1998). Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702705. doi: 10.1038/31508.Google Scholar
Im, S., Kim, Y. E. and Kim, Y. J. (2015). Genetics of progressive supranuclear palsy. Journal of Movement Disorders, 8, 122129. doi: 10.14802/jmd.15033.Google Scholar
Irwin, D. (2015). Tauopathies as clinicopathological entities. Parkinsonism and Related Disorders, 22, 2933. doi: 10.1016/j.parkreldis.2015.09.020.Google Scholar
Kasuga, K. et al. (2015). Short communication - systematic review and meta-analysis of Japanese familial Alzheimer's disease and FTDP-17. Journal of Human Genetics, 60, 281283. doi: 10.1038/jhg.2015.15.CrossRefGoogle Scholar
Lambert, M. et al. (2014). Estimating the burden of early onset dementia; systematic review of disease prevalence. European Journal of Neurology, 21, 563569. doi: 10.1111/ene.12325.Google Scholar
Rademakers, R. et al. (2003). Tau (MAPT) mutation Arg406Trp presenting clinically with Alzheimer's disease does not share a common founder in Western Europe. Human Mutation, 22, 409411. doi: 10.1002/humu.10269.Google Scholar
Reed, L., Wszolek, Z. K. and Hutton, M. (2001). Phenotypic correlations in FTDP-17. Neurobiol Aging 22, 89107. PMID: 11164280.Google Scholar
Sperfeld, A. et al. (1999). FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation. Annals of Neurology, 46, 708715. PMID: 10553987.Google Scholar
Wszolek, Z., Tsuboi, Y., Ghetti, B., Pickering-Brown, S., Baba, Y. and Cheshire, W. P. (2006). Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Orphanet Journal of Rare Diseases, 30, 19. doi: 10.1186/1750-1172-1-30 Google Scholar